AU5322900A - Modulation of protein levels using the scf complex - Google Patents

Modulation of protein levels using the scf complex

Info

Publication number
AU5322900A
AU5322900A AU53229/00A AU5322900A AU5322900A AU 5322900 A AU5322900 A AU 5322900A AU 53229/00 A AU53229/00 A AU 53229/00A AU 5322900 A AU5322900 A AU 5322900A AU 5322900 A AU5322900 A AU 5322900A
Authority
AU
Australia
Prior art keywords
modulation
protein levels
scf complex
scf
complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU53229/00A
Other languages
English (en)
Inventor
Takeshi Kondo
Lyuben M. Tsvetkov
Hui Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yale University
Original Assignee
Yale University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yale University filed Critical Yale University
Publication of AU5322900A publication Critical patent/AU5322900A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU53229/00A 1999-06-04 2000-06-05 Modulation of protein levels using the scf complex Abandoned AU5322900A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13749499P 1999-06-04 1999-06-04
US60137494 1999-06-04
PCT/US2000/015449 WO2000075184A1 (fr) 1999-06-04 2000-06-05 Modulation de taux de proteines au moyen du complexe scf

Publications (1)

Publication Number Publication Date
AU5322900A true AU5322900A (en) 2000-12-28

Family

ID=22477683

Family Applications (1)

Application Number Title Priority Date Filing Date
AU53229/00A Abandoned AU5322900A (en) 1999-06-04 2000-06-05 Modulation of protein levels using the scf complex

Country Status (2)

Country Link
AU (1) AU5322900A (fr)
WO (1) WO2000075184A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001520885A (ja) * 1997-10-29 2001-11-06 ジェネンテック・インコーポレーテッド Ｗｎｔ−１誘導遺伝子
US6306663B1 (en) 1999-02-12 2001-10-23 Proteinex, Inc. Controlling protein levels in eucaryotic organisms
AU2002240892A1 (en) * 2001-01-02 2002-07-16 Centre National De La Recherche Scientifique Protein-protein interactions in adipocyte cells
CA2433795A1 (fr) * 2001-01-05 2002-07-18 New York University Procedes destines a identifier des composes utiles dans le traitement de troubles de proliferation et de differenciation
CA2353002C (fr) 2001-07-13 2009-12-01 Teck Cominco Metals Ltd. Processus de biolixiviation en tas pour extraire le zinc
US7455715B2 (en) 2001-07-13 2008-11-25 Teck Cominco Metals Ltd. Heap bioleaching process for the extraction of zinc
FR2828208A1 (fr) * 2001-08-01 2003-02-07 Cytomics Systems Acides nucleiques codant de nouvelles proteines a boite f, leurs utilisations en diagnostic et en therapie
JP4972538B2 (ja) 2005-02-07 2012-07-11 武田薬品工業株式会社 神経変性疾患の予防・治療剤
GB0803352D0 (en) 2008-02-22 2008-04-02 Ntnu Technology Transfer As Oligopeptidic compounds and uses thereof
CN105473742A (zh) 2013-06-24 2016-04-06 米尔纳疗法公司 miR-34活性的生物标志物
EP4204812A2 (fr) * 2020-08-27 2023-07-05 Otsuka Pharmaceutical Co., Ltd. Biomarqueurs pour la thérapie anticancéreuse utilisant des antagonistes de mdm2

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981702A (en) * 1995-09-21 1999-11-09 Cold Spring Harbor Laboratory Cyclin/CDK associated proteins, and uses related thereto
US6573094B1 (en) * 1997-10-16 2003-06-03 Baylor College Of Medicine F-box genes and proteins

Also Published As

Publication number Publication date
WO2000075184A9 (fr) 2002-04-18
WO2000075184A1 (fr) 2000-12-14

Similar Documents

Publication Publication Date Title
AU2212600A (en) Antisense modulation of g-alpha-i1 expression
AU6296099A (en) Antisense modulation of g-alpha-12 expression
AU5173400A (en) Protein kinases
AU6296199A (en) Antisense modulation of smad1 expression
AU4193700A (en) Antisense oligonucleotide compositions and methods for the modulation of jnk proteins
AU3867400A (en) Methods of using bioelastomers
AU5468499A (en) 3-methylidenyl-2-indolinone modulators of protein kinase
AU2492000A (en) Implantable neuro-stimulator
AU2361901A (en) New colouring combination
AU1878601A (en) Enzyme
AU2880400A (en) Tnf-related proteins
AU6045900A (en) Interaction-activated proteins
AU6115400A (en) Antisense modulation of mekk5 expression
AU7876900A (en) Antisense modulation of fra-1 expression
AU6109200A (en) Antisense modulation of shp-2 expression
AU5322900A (en) Modulation of protein levels using the scf complex
AU1608201A (en) Human zven proteins
AU2209000A (en) Antisense modulation of pepck-mitochondrial expression
AU5486700A (en) Antisense modulation of g-alpha-s1 expression
AU2213600A (en) Antisense modulation of mdmx expression
AU2410600A (en) Antisense modulation of g-alpha-i3 expression
AU4188500A (en) Protein c derivatives
AU3155201A (en) New colouring combination
AU6045499A (en) Antisense modulation of crel expression
AU5874800A (en) Antisense modulation of ets-2 expression

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase